Top

Child's Nervous System

Published in:

01-08-2019 | Retinoblastoma | Original Article

MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8

Authors: Bingqian Liu, Baiyang Lu, Xue Wang, Haitao Jiang, Weiwei Kuang

Published in: Child's Nervous System | Issue 8/2019

Abstract

Purpose

MiR-361-5p has been reported to act as tumor suppressor in several types of cancers. Retinoblastoma (RB) is the most common ocular tumor in childhood. The current study aimed to investigate the expression pattern and biological function of miR-361-5p in RB.

Methods

Quantitative real time was utilized to determine and compare the expression of miR-361-5p in RB cells and normal retinal pigment epithelial cell line ARPE-19. CCK-8 and Edu assay were performed to assess cell proliferation. Cell apoptosis was evaluated using flow cytometry assay. Bioinformatics databases and luciferase reporter assay were applied to predict and confirm the target gene of miR-361-5p in RB cells.

Results

Here, we found miR-361-5p was significantly downregulated in RB cells compared with normal retinal pigment epithelial cell line ARPE-19. MiR-361-5p overexpression significantly inhibited or silencing promoted cell proliferation in Y79 and SO-RB50 cells, respectively. Flow cytometry assay showed a significantly decreased cell apoptosis in miR-361-5p silencing Y79 cells and increased cell apoptosis in miR-361-5p overexpressing SO-RB50 cells. Moreover, miR-361-5p directly bound to the 3′ untranslated region of claudin 8 (CLDN8) and inhibited the expression of CLDN8. Furthermore, we found knockdown of CLDN8 photocopied the effect of miR-361-5p on cell proliferation and apoptosis in RB cells.

Conclusion

These results indicated that overexpression of miR-361-5p might act as a suppressor in RB by targeting CLDN8 to inhibit the cellular function.

Fernandes AG, Pollock BD, Rabito FA (2018) Retinoblastoma in the United States: a 40-year incidence and survival analysis. J Pediatr Ophthalmol Strabismus 55:182–188. https://doi.org/10.3928/01913913-20171116-03 CrossRefPubMed

Theriault BL, Dimaras H, Gallie BL, Corson TW (2014) The genomic landscape of retinoblastoma: a review. Clin Exp Ophthalmol 42:33–52. https://doi.org/10.1111/ceo.12132 CrossRefPubMed

Li WL, Buckley J, Sanchez-Lara PA, Maglinte DT, Viduetsky L, Tatarinova TV, Aparicio JG, Kim JW, Au M, Ostrow D, Lee TC, O’Gorman M, Judkins A, Cobrinik D, Triche TJ (2016) A rapid and sensitive next-generation sequencing method to detect RB1 mutations improves care for retinoblastoma patients and their families. J Mol Diagn 18:480–493. https://doi.org/10.1016/j.jmoldx.2016.02.006 CrossRefPubMedPubMedCentral

Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, Gallie BL (2015) Retinoblastoma. Nature Reviews Disease Primers 1:15021. https://doi.org/10.1038/nrdp.2015.21 https://www.nature.com/articles/nrdp201521#supplementary-information CrossRefPubMedPubMedCentral

Nishikawa R, Chiyomaru T, Enokida H, Inoguchi S, Ishihara T, Matsushita R, Goto Y, Fukumoto I, Nakagawa M, Seki N (2015) Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma. FEBS Lett 589:2136–2145. https://doi.org/10.1016/j.febslet.2015.06.005 CrossRefPubMed

Desvignes T, Batzel P, Berezikov E, Eilbeck K, Eppig JT, McAndrews MS, Singer A, Postlethwait JH (2015) miRNA nomenclature: a view incorporating genetic origins, biosynthetic pathways, and sequence variants. Trends Genet 31:613–626. https://doi.org/10.1016/j.tig.2015.09.002 CrossRefPubMedPubMedCentral

Wilczynska A, Bushell M (2015) The complexity of miRNA-mediated repression. Cell Death Differ 22:22–33. https://doi.org/10.1038/cdd.2014.112 CrossRefPubMed

Oliveto S, Mancino M, Manfrini N, Biffo S (2017) Role of microRNAs in translation regulation and cancer. World J Biol Chem 8:45–56. https://doi.org/10.4331/wjbc.v8.i1.45 CrossRefPubMedPubMedCentral

Acunzo M, Romano G, Wernicke D, Croce CM (2015) MicroRNA and cancer--a brief overview. Adv Biol Regul 57:1–9. https://doi.org/10.1016/j.jbior.2014.09.013 CrossRefPubMed

10.

Ma F, Song H, Guo B, Zhang Y, Zheng Y, Lin C, Wu Y, Guan G, Sha R, Zhou Q, Wang D, Zhou X, Li J, Qiu X (2015) MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1. Oncotarget 6:17404–17416. https://doi.org/10.18632/oncotarget.3744 CrossRefPubMedPubMedCentral

11.

Liu D, Tao T, Xu B, Chen S, Liu C, Zhang L, Lu K, Huang Y, Jiang L, Zhang X, Huang X, Zhang L, Han C, Chen M (2014) MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). Biochem Biophys Res Commun 445:151–156. https://doi.org/10.1016/j.bbrc.2014.01.140 CrossRefPubMed

12.

Hou XW, Sun X, Yu Y, Zhao HM, Yang ZJ, Wang X, Cao XC (2017) miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1. Neoplasma 64:526–534. https://doi.org/10.4149/neo_2017_406 CrossRefPubMed

13.

Zhang X, Shao R, Gao W, Sun G, Liu Y, Fa X (2018) Inhibition of miR-361-5p suppressed pulmonary artery smooth muscle cell survival and migration by targeting ABCA1 and inhibiting the JAK2/STAT3 pathway. Exp Cell Res 363:255–261. https://doi.org/10.1016/j.yexcr.2018.01.015 CrossRefPubMed

14.

Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE (2015) Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects. Semin Cell Dev Biol 38:16–25. https://doi.org/10.1016/j.semcdb.2014.11.004 CrossRef

15.

Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285–293. https://doi.org/10.1038/35067088 CrossRefPubMed

16.

Ouban A, Ahmed AA (2010) Claudins in human cancer: a review. Histol Histopathol 25:83–90. https://doi.org/10.14670/HH-25.83 CrossRefPubMed

17.

Jauregi-Miguel A, Fernandez-Jimenez N, Irastorza I, Plaza-Izurieta L, Vitoria JC, Bilbao JR (2014) Alteration of tight junction gene expression in celiac disease. J Pediatr Gastroenterol Nutr 58:762–767. https://doi.org/10.1097/MPG.0000000000000338 CrossRefPubMed

18.

Lerner A, Matthias T (2015) Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 14:479–489. https://doi.org/10.1016/j.autrev.2015.01.009 CrossRef

19.

Landy J, Ronde E, English N, Clark SK, Hart AL, Knight SC, Ciclitira PJ, Al-Hassi HO (2016) Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol 22:3117–3126. https://doi.org/10.3748/wjg.v22.i11.3117 CrossRefPubMedPubMedCentral

20.

Singh AB, Dhawan P (2015) Claudins and cancer: fall of the soldiers entrusted to protect the gate and keep the barrier intact. Semin Cell Dev Biol 42:58–65. https://doi.org/10.1016/j.semcdb.2015.05.001 CrossRef

21.

Xu J, Yang Y, Hao P, Ding X (2015) Claudin 8 contributes to malignant proliferation in human osteosarcoma U2OS cells. Cancer Biother Radiopharm 30:400–404. https://doi.org/10.1089/cbr.2015.1815 CrossRefPubMed

22.

Ashikari D, Takayama KI, Obinata D, Takahashi S, Inoue S (2017) CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration. Cancer Sci 108:1386–1393. https://doi.org/10.1111/cas.13269 CrossRefPubMedPubMedCentral

23.

Mataki H, Enokida H, Chiyomaru T, Mizuno K, Matsushita R, Goto Y, Nishikawa R, Higashimoto I, Samukawa T, Nakagawa M, Inoue H, Seki N (2015) Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. J Hum Genet 60:53–61. https://doi.org/10.1038/jhg.2014.111 CrossRefPubMed

24.

Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, Hofbauer GF, Gerber AP, Detmar M (2012) The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One 7:e49568. https://doi.org/10.1371/journal.pone.0049568 CrossRefPubMedPubMedCentral

25.

Tsukita S, Tanaka H, Tamura A (2019) The claudins: from tight junctions to biological systems. Trends Biochem Sci 2018. https://doi.org/10.1016/j.tibs.2018.09.008

26.

Van Itallie CM, Colegio OR, Anderson JM (2004) The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability. J Membr Biol 199:29–38CrossRefPubMed

27.

Van Itallie CM, Anderson JM (2014) Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol 36:157–165. https://doi.org/10.1016/j.semcdb.2014.08.011 CrossRef

28.

Gonzalez-Mariscal L, Miranda J, Raya-Sandino A, Dominguez-Calderon A, Cuellar-Perez F (2017) ZO-2, a tight junction protein involved in gene expression, proliferation, apoptosis, and cell size regulation. Ann N Y Acad Sci 1397:35–53. https://doi.org/10.1111/nyas.13334 CrossRefPubMed

29.

Cordenonsi M (2015) ZO-oming on growth control by junctional proteins. Cell Cycle 14:472. https://doi.org/10.1080/15384101.2015.1006557 CrossRefPubMedPubMedCentral

30.

Chidiac R, Zhang Y, Tessier S, Faubert D, Delisle C, Gratton JP (2016) Comparative phosphoproteomics analysis of VEGF and angiopoietin-1 signaling reveals ZO-1 as a critical regulator of endothelial cell proliferation. Mol Cell Proteomics 15:1511–1525. https://doi.org/10.1074/mcp.M115.053298 CrossRefPubMedPubMedCentral

31.

Bai L, Mao R, Wang J, Ding L, Jiang S, Gao C, Kang H, Chen X, Sun X, Xu J (2015) ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. Med Oncol 32:57. https://doi.org/10.1007/s12032-015-0490-5 CrossRefPubMed

32.

Lawlor MA, Alessi DR:2001 PKB/Akt. A key mediator of cell proliferation, survival and insulin responses? , 114:2903–2910

Title: MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8
Authors: Bingqian Liu
Baiyang Lu
Xue Wang
Haitao Jiang
Weiwei Kuang
Publication date: 01-08-2019
Publisher: Springer Berlin Heidelberg
Keywords: Retinoblastoma
Retinoblastoma
Published in: Child's Nervous System / Issue 8/2019
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-019-04199-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2019

Outcome of postoperative radiation therapy for pediatric intracranial ependymoma: a single-institution review

Management of pediatric CNS meningiomas: CCHE-57357 experience in 39 cases

Strabismus in hydrocephalus patients

Cervical intradural extramedullary epidermoid cyst at the background of congenital scoliosis with a semi-segmented C6 hemivertebra

Basilar invagination in a child with atlanto-occipital subluxation and suspected prenatal Dandy–Walker malformation

A singular association of migraine with brainstem aura and Alice in Wonderland syndrome